Suppr超能文献

精神障碍多基因风险评分:儿童和青少年精神科医生的知识、态度和经验。

Psychiatric polygenic risk scores: Child and adolescent psychiatrists' knowledge, attitudes, and experiences.

机构信息

Center for Medical Ethics and Health Policy, Baylor College of Medicine, Houston, Texas, USA.

School of Medicine, Emory University, Atlanta, Georgia, USA.

出版信息

Am J Med Genet B Neuropsychiatr Genet. 2022 Oct;189(7-8):293-302. doi: 10.1002/ajmg.b.32912. Epub 2022 Jul 6.

Abstract

Psychiatric polygenic risk scores (PRS) have potential utility in psychiatric care and prevention, but there are concerns about their implementation. We surveyed 960 US-based practicing child and adolescent psychiatrists' (CAP) about their experiences, perspectives, and potential uses of psychiatric PRS. While 23% of CAP reported that they had never heard of PRS, 10 % of respondents have had a patient/family bring PRS to them and 4% have generated PRS for patients. Though 25% stated they would request PRS if a patient/caregiver asked, 35% indicated that nothing would prompt them to request PRS. Most respondents (54%) believed psychiatric PRS are currently at least slightly useful and 87% believed they will be so in 5 years. More than 70% indicated they would take action in response to a child with a top fifth percentile psychiatric PRS but no diagnosis: 48% would increase monitoring of symptoms, 42% would evaluate for current symptoms, and 4% would prescribe medications. Yet, most respondents were concerned that high-PRS results could lead to overtreatment and negatively impact patients' emotional well-being. Findings indicate emerging use of psychiatric PRS within child and adolescent psychiatry in the US. It is critical to examine the ethical and clinical challenges that PRS may generate and begin efforts to promote their informed and responsible use.

摘要

精神科多基因风险评分(PRS)在精神科护理和预防方面具有潜在的应用价值,但人们对其实施存在一些担忧。我们调查了 960 名美国执业儿童和青少年精神科医生(CAP),了解他们在精神科 PRS 方面的经验、观点和潜在用途。虽然 23%的 CAP 报告称他们从未听说过 PRS,但有 10%的受访者曾有患者/家属向他们提及 PRS,4%的受访者曾为患者生成 PRS。尽管 25%的受访者表示如果患者/照顾者提出要求,他们会要求 PRS,但 35%的受访者表示没有任何因素会促使他们要求 PRS。大多数受访者(54%)认为精神科 PRS 目前至少有一定的用处,87%的受访者认为 5 年后会如此。超过 70%的受访者表示,他们会对 PRS 排名在前五分之一但没有诊断的儿童采取行动:48%的人会增加对症状的监测,42%的人会评估当前症状,4%的人会开处方。然而,大多数受访者担心高 PRS 结果可能导致过度治疗,并对患者的情绪健康产生负面影响。研究结果表明,精神科 PRS 在美国儿童和青少年精神科领域的应用正在兴起。重要的是要检查 PRS 可能产生的伦理和临床挑战,并开始努力促进其知情和负责任的使用。

相似文献

1
Psychiatric polygenic risk scores: Child and adolescent psychiatrists' knowledge, attitudes, and experiences.
Am J Med Genet B Neuropsychiatr Genet. 2022 Oct;189(7-8):293-302. doi: 10.1002/ajmg.b.32912. Epub 2022 Jul 6.
2
Psychiatric polygenic risk scores: Experience, hope for utility, and concerns among child and adolescent psychiatrists.
Psychiatry Res. 2024 Sep;339:116080. doi: 10.1016/j.psychres.2024.116080. Epub 2024 Jul 7.
3
Child and adolescent psychiatrists' use, attitudes, and understanding of genetic testing and pharmacogenetics in clinical practice.
Psychiatry Res. 2023 Jul;325:115246. doi: 10.1016/j.psychres.2023.115246. Epub 2023 May 6.
4
How do experts in psychiatric genetics view the clinical utility of polygenic risk scores for schizophrenia?
Am J Med Genet B Neuropsychiatr Genet. 2023 Oct-Dec;192(7-8):161-170. doi: 10.1002/ajmg.b.32939. Epub 2023 May 9.
5
Could Polygenic Risk Scores Be Useful in Psychiatry?: A Review.
JAMA Psychiatry. 2021 Feb 1;78(2):210-219. doi: 10.1001/jamapsychiatry.2020.3042.
6
Child and Adolescent Psychiatrists' Use, Attitudes, and Understanding of Genetic Tests in Clinical Practice.
medRxiv. 2023 Jan 28:2023.01.24.23284953. doi: 10.1101/2023.01.24.23284953.
7
Psychiatrists' attitudes toward metabolic adverse events in patients with schizophrenia.
PLoS One. 2014 Jan 23;9(1):e86826. doi: 10.1371/journal.pone.0086826. eCollection 2014.
8
Psychiatrists' knowledge and attitudes about costs of commonly prescribed treatments in psychiatry.
J Community Health. 2001 Feb;26(1):11-22. doi: 10.1023/a:1026533013729.
9
Child and adolescent psychiatrists' attitudes and practices prescribing second generation antipsychotics.
J Child Adolesc Psychopharmacol. 2014 Mar;24(2):90-3. doi: 10.1089/cap.2013.0133.

引用本文的文献

2
Review: Child Psychiatry in the Era of Genomics: The Promise of Translational Genetics Research for the Clinic.
JAACAP Open. 2024 Aug 9;3(2):157-170. doi: 10.1016/j.jaacop.2024.06.002. eCollection 2025 Jun.
4
Navigating the Future of Polygenic Risk Scores: Insights from Child and Adolescent Psychiatrists.
Child Psychiatry Hum Dev. 2025 May 17. doi: 10.1007/s10578-025-01854-y.
5
Polygenic risk scores in the clinic: a systematic review of stakeholders' perspectives, attitudes, and experiences.
Eur J Hum Genet. 2025 Mar;33(3):266-280. doi: 10.1038/s41431-024-01747-z. Epub 2024 Nov 23.
6
Psychiatric polygenic risk scores: Experience, hope for utility, and concerns among child and adolescent psychiatrists.
Psychiatry Res. 2024 Sep;339:116080. doi: 10.1016/j.psychres.2024.116080. Epub 2024 Jul 7.
8
Child and adolescent psychiatrists' use, attitudes, and understanding of genetic testing and pharmacogenetics in clinical practice.
Psychiatry Res. 2023 Jul;325:115246. doi: 10.1016/j.psychres.2023.115246. Epub 2023 May 6.
9
How do experts in psychiatric genetics view the clinical utility of polygenic risk scores for schizophrenia?
Am J Med Genet B Neuropsychiatr Genet. 2023 Oct-Dec;192(7-8):161-170. doi: 10.1002/ajmg.b.32939. Epub 2023 May 9.

本文引用的文献

1
2
Why do people seek out polygenic risk scores for complex disorders, and how do they understand and react to results?
Eur J Hum Genet. 2022 Jan;30(1):81-87. doi: 10.1038/s41431-021-00929-3. Epub 2021 Jul 19.
3
Problems with Using Polygenic Scores to Select Embryos.
N Engl J Med. 2021 Jul 1;385(1):78-86. doi: 10.1056/NEJMsr2105065.
4
Child and Adolescent Psychiatrists' Perceptions of Utility and Self-rated Knowledge of Genetic Testing Predict Usage for Autism Spectrum Disorder.
J Am Acad Child Adolesc Psychiatry. 2021 Jun;60(6):657-660. doi: 10.1016/j.jaac.2021.01.022. Epub 2021 Feb 18.
5
6
Screening embryos for polygenic conditions and traits: ethical considerations for an emerging technology.
Genet Med. 2021 Mar;23(3):432-434. doi: 10.1038/s41436-020-01019-3. Epub 2020 Oct 27.
7
Could Polygenic Risk Scores Be Useful in Psychiatry?: A Review.
JAMA Psychiatry. 2021 Feb 1;78(2):210-219. doi: 10.1001/jamapsychiatry.2020.3042.
8
Return of results in a global survey of psychiatric genetics researchers: practices, attitudes, and knowledge.
Genet Med. 2021 Feb;23(2):298-305. doi: 10.1038/s41436-020-00986-x. Epub 2020 Oct 9.
9
From Basic Science to Clinical Application of Polygenic Risk Scores: A Primer.
JAMA Psychiatry. 2021 Jan 1;78(1):101-109. doi: 10.1001/jamapsychiatry.2020.3049.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验